• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏干细胞在人类心脏中的分布。

Distribution of cardiac stem cells in the human heart.

作者信息

Arsalan Mani, Woitek Felix, Adams Volker, Linke Axel, Barten Markus J, Dhein Stefan, Walther Thomas, Mohr Friedrich-Wilhelm, Garbade Jens

机构信息

Department of Cardiac Surgery, Kerckhoff Klinik, Bad Nauheim, Benekestr. 2-8, 61231 Bad Nauheim,, Germany.

出版信息

ISRN Cardiol. 2012;2012:483407. doi: 10.5402/2012/483407. Epub 2012 Mar 4.

DOI:10.5402/2012/483407
PMID:22462025
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3312548/
Abstract

Introduction. The existence of human cardiac stem cells (hCSC) and their regenerative capacity are not fully defined. The aim of this study was to identify and analyse the distribution of hCSCs by flow cytometry (FCM). Methods. Tissue samples from the left ventricle (LV) and the appendages of the right atrium (RA) and left atrium (LA) were taken during cardiac surgery. Mononuclear cells (MNCs) were isolated, labelled for the stem-cell-marker c-kit and hematopoietic-lineage markers and analysed by FCM. Results. HCSCs could be isolated from the RA, LA, and LV without significant quantitative difference between both atria (A) (RA 4.80 ± 1.76% versus LA 4.99 ± 1.69% of isolated MNCs, P = 0.922). The number of hCSCs was significantly higher in both atria compared to the left ventricle (A 4.90 ± 1.29% versus LV 0.62 ± 0.14% of isolated MNCs, P = 0.035). Conclusion. The atria contain a higher concentration of hCSC than the left ventricle. HCSCs located in the atria could serve as an endogenous source for heart regeneration.

摘要

引言。人类心脏干细胞(hCSC)的存在及其再生能力尚未完全明确。本研究的目的是通过流式细胞术(FCM)鉴定并分析hCSC的分布。方法。在心脏手术期间采集左心室(LV)以及右心房(RA)和左心房(LA)附属结构的组织样本。分离单核细胞(MNC),用干细胞标志物c-kit和造血谱系标志物进行标记,并通过FCM进行分析。结果。可从RA、LA和LV中分离出hCSC,两个心房之间无显著数量差异(分离的MNC中,RA为4.80±1.76%,LA为4.99±1.69%,P = 0.922)。与左心室相比,两个心房中的hCSC数量显著更高(分离的MNC中,心房为4.90±1.29%,LV为0.62±0.14%,P = 0.035)。结论。心房中hCSC的浓度高于左心室。位于心房的hCSC可作为心脏再生的内源性来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8e/3312548/74f3af707a7c/ISRN.CARDIOLOGY2012-483407.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8e/3312548/1b43c097d02b/ISRN.CARDIOLOGY2012-483407.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8e/3312548/2c0b795e51d1/ISRN.CARDIOLOGY2012-483407.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8e/3312548/8a6157f01ba5/ISRN.CARDIOLOGY2012-483407.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8e/3312548/74f3af707a7c/ISRN.CARDIOLOGY2012-483407.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8e/3312548/1b43c097d02b/ISRN.CARDIOLOGY2012-483407.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8e/3312548/2c0b795e51d1/ISRN.CARDIOLOGY2012-483407.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8e/3312548/8a6157f01ba5/ISRN.CARDIOLOGY2012-483407.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8e/3312548/74f3af707a7c/ISRN.CARDIOLOGY2012-483407.004.jpg

相似文献

1
Distribution of cardiac stem cells in the human heart.心脏干细胞在人类心脏中的分布。
ISRN Cardiol. 2012;2012:483407. doi: 10.5402/2012/483407. Epub 2012 Mar 4.
2
Preconditioning Human Cardiac Stem Cells with an HO-1 Inducer Exerts Beneficial Effects After Cell Transplantation in the Infarcted Murine Heart.用HO-1诱导剂预处理人心脏干细胞在梗死小鼠心脏细胞移植后发挥有益作用。
Stem Cells. 2015 Dec;33(12):3596-607. doi: 10.1002/stem.2198. Epub 2015 Sep 23.
3
Safety of intracoronary infusion of 20 million C-kit positive human cardiac stem cells in pigs.猪冠状动脉内输注2000万个C-试剂盒阳性人心脏干细胞的安全性。
PLoS One. 2015 Apr 23;10(4):e0124227. doi: 10.1371/journal.pone.0124227. eCollection 2015.
4
Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells.患者特征和细胞来源决定了分离的人心脏祖细胞的数量。
Circulation. 2009 Dec 22;120(25):2559-66. doi: 10.1161/CIRCULATIONAHA.109.849588. Epub 2009 Dec 7.
5
Human cardiac stem cells rejuvenated by modulating autophagy with MHY-1685 enhance the therapeutic potential for cardiac repair.用 MHY-1685 调节自噬作用使人心肌干细胞年轻化,增强心脏修复的治疗潜力。
Exp Mol Med. 2021 Sep;53(9):1423-1436. doi: 10.1038/s12276-021-00676-x. Epub 2021 Sep 28.
6
Distribution and homing pattern of c-kit+ Sca-1+ CXCR4+ resident cardiac stem cells in neonatal, postnatal, and adult mouse heart.c-kit+Sca-1+CXCR4+ 心脏固有干细胞在新生、出生后和成年小鼠心脏中的分布和归巢模式。
Cardiovasc Pathol. 2013 Jul-Aug;22(4):257-63. doi: 10.1016/j.carpath.2012.11.002. Epub 2012 Dec 27.
7
Combination of Cardiac Progenitor Cells From the Right Atrium and Left Ventricle Exhibits Synergistic Paracrine Effects In Vitro.右心房和左心室的心脏祖细胞联合具有协同的旁分泌作用。
Cell Transplant. 2020 Jan-Dec;29:963689720972328. doi: 10.1177/0963689720972328.
8
Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration.人类心脏驻留干细胞:在心脏细胞内环境稳定中的作用及心肌再生潜力
Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S8-13. doi: 10.1038/ncpcardio0409.
9
Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues.成人心脏干细胞补充可有效增加人心肌组织工程中的收缩功能和成熟度。
Stem Cell Res Ther. 2019 Dec 4;10(1):373. doi: 10.1186/s13287-019-1486-4.
10
Keratose Hydrogels Promote Vascular Smooth Muscle Differentiation from C-kit-Positive Human Cardiac Stem Cells.角质化水凝胶促进C-kit阳性人心脏干细胞向血管平滑肌分化。
Stem Cells Dev. 2017 Jun 15;26(12):888-900. doi: 10.1089/scd.2016.0351. Epub 2017 Apr 24.

引用本文的文献

1
In vitro CSC-derived cardiomyocytes exhibit the typical microRNA-mRNA blueprint of endogenous cardiomyocytes.在体外培养的 CSC 衍生的心肌细胞中表现出内源性心肌细胞典型的 microRNA-mRNA 蓝图。
Commun Biol. 2021 Sep 30;4(1):1146. doi: 10.1038/s42003-021-02677-y.
2
Substance P enhances the local activation of NKR-expressing c-kit cardiac progenitor cells in right atrium of ischemia/reperfusion-injured heart.P 物质增强表达 NKR 的 c-kit 心脏祖细胞在缺血/再灌注损伤心脏右心房的局部激活。
BMC Mol Cell Biol. 2020 Jun 9;21(1):41. doi: 10.1186/s12860-020-00286-x.
3
Qualitative and Quantitative Analysis of Cardiac Progenitor Cells in Cases of Myocarditis and Cardiomyopathy.

本文引用的文献

1
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy.祖细胞移植与急性心肌梗死的再生增强(TOPCARE-AMI):最终 5 年结果提示长期安全性和疗效。
Clin Res Cardiol. 2011 Oct;100(10):925-34. doi: 10.1007/s00392-011-0327-y. Epub 2011 Jun 3.
2
Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration.人骨髓间充质干细胞的细胞起源决定了其在心脏再生中的不同修复性能。
PLoS One. 2011 Feb 10;6(2):e15652. doi: 10.1371/journal.pone.0015652.
3
Characterization and functionality of cardiac progenitor cells in congenital heart patients.
心肌炎和心肌病病例中心脏祖细胞的定性和定量分析
Front Genet. 2018 Mar 6;9:72. doi: 10.3389/fgene.2018.00072. eCollection 2018.
4
Contemporary perspective on endogenous myocardial regeneration.内源性心肌再生的当代观点。
World J Stem Cells. 2015 Jun 26;7(5):793-805. doi: 10.4252/wjsc.v7.i5.793.
5
THY-1 receptor expression differentiates cardiosphere-derived cells with divergent cardiogenic differentiation potential.THY-1 受体表达可区分具有不同心肌发生分化潜能的心球衍生细胞。
Stem Cell Reports. 2014 Apr 18;2(5):576-91. doi: 10.1016/j.stemcr.2014.03.003. eCollection 2014 May 6.
6
Endogenous cardiac stem cells for the treatment of heart failure.用于治疗心力衰竭的内源性心脏干细胞
Stem Cells Cloning. 2013 Mar 25;6:1-12. doi: 10.2147/SCCAA.S29221.
先天性心脏病患者中心脏祖细胞的特征和功能。
Circulation. 2011 Feb 1;123(4):364-73. doi: 10.1161/CIRCULATIONAHA.110.971622. Epub 2011 Jan 17.
4
Synergistic effect of adipose-derived stem cell therapy and bone marrow progenitor recruitment in ischemic heart.脂肪干细胞治疗与骨髓祖细胞募集在缺血性心脏中的协同作用。
Lab Invest. 2011 Apr;91(4):539-52. doi: 10.1038/labinvest.2010.191. Epub 2010 Dec 6.
5
Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study.自体骨髓单个核细胞心肌内注射治疗缺血性心力衰竭的疗效:一项随机研究。
J Cardiovasc Transl Res. 2010 Apr;3(2):160-8. doi: 10.1007/s12265-009-9123-8. Epub 2009 Sep 24.
6
New insights into paracrine mechanisms of human cardiac progenitor cells.对人心肌祖细胞旁分泌机制的新认识。
Eur J Heart Fail. 2010 Jul;12(7):730-7. doi: 10.1093/eurjhf/hfq063. Epub 2010 Apr 20.
7
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction.冠状动脉内注射心脏祖细胞可减轻 30 日龄大鼠梗死模型的左心室功能障碍。
Circulation. 2010 Jan 19;121(2):293-305. doi: 10.1161/CIRCULATIONAHA.109.871905. Epub 2010 Jan 4.
8
Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction.急性心肌梗死后 2 年经冠状动脉内骨髓源性祖细胞治疗的临床结果。
Circ Heart Fail. 2010 Jan;3(1):89-96. doi: 10.1161/CIRCHEARTFAILURE.108.843243. Epub 2009 Dec 8.
9
Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function.心脏祖细胞的局部激活或植入可挽救瘢痕化梗死心肌,改善心脏功能。
Circ Res. 2008 Jul 3;103(1):107-16. doi: 10.1161/CIRCRESAHA.108.178525. Epub 2008 Jun 12.
10
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.缺血性心肌病成肌细胞自体移植(MAGIC)试验:成肌细胞移植的首个随机安慰剂对照研究。
Circulation. 2008 Mar 4;117(9):1189-200. doi: 10.1161/CIRCULATIONAHA.107.734103. Epub 2008 Feb 19.